PREXTON THERAPEUTICS
Prexton Therapeutics is a Swiss-based biopharmaceutical company, founded in 2012 by Francois Conquet and MS Ventures as part of the Merck Serono Entrepreneur Partnership Program, a facility to support the creation of spin-offs from Merck Serono. Prexton Therapeutics applies a new scientific approach that fully integrates molecular, behavioural and chemistry technologies to address Parkinson’s disease and other brain disorders. Prexton Therapeutics uses its powerful discovery platform to target specific novel compounds focused on the treatment of Parkinson’s disease.
PREXTON THERAPEUTICS
Social Links:
Industry:
Health Care Medical Pharmaceutical
Founded:
2012-01-01
Address:
Plan-les-ouates, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.prextontherapeutics.com
Total Employee:
1+
Status:
Closed
Contact:
+41227069010
Email Addresses:
[email protected]
Total Funding:
41.07 M USD
Technology used in webpage:
Domain Not Resolving Euro Infomaniak Network
Current Advisors List
Founder
Investors List
Ysios Capital
Ysios Capital investment in Series B - Prexton Therapeutics
M Ventures
M Ventures investment in Series B - Prexton Therapeutics
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Prexton Therapeutics
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Series B - Prexton Therapeutics
Seroba Life Sciences
Seroba Life Sciences investment in Series B - Prexton Therapeutics
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Series A - Prexton Therapeutics
Ysios Capital
Ysios Capital investment in Series A - Prexton Therapeutics
M Ventures
M Ventures investment in Series A - Prexton Therapeutics
Eclosion SA
Eclosion SA investment in Seed Round - Prexton Therapeutics
Official Site Inspections
http://www.prextontherapeutics.com
- Host name: 172.65.235.97
- IP address: 172.65.235.97
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Prexton Therapeutics"
Prexton Therapeutics - Crunchbase Company Profile & Funding
Prexton Therapeutics is a Swiss-based biopharmaceutical company, founded in 2012 by Francois Conquet and MS Ventures as part of the Merck Serono Entrepreneur Partnership Program, a …See details»
Prexton Therapeutics Company Profile 2024: Valuation, Investors ...
Prexton Therapeutics is headquartered in Oss, Netherlands. What is the size of Prexton Therapeutics? Prexton Therapeutics has 5 total employees. What industry is Prexton …See details»
Prexton Therapeutics - Craft
Prexton Therapeutics is a Swiss-based biopharmaceutical company, founded in 2012 by Francois Conquet and MS Ventures as part of the Merck Serono Entrepreneur Partnership Program, a …See details»
Prexton Therapeutics | Company | RadialReport
Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life. Prexton Therapeutics is a Swiss-based biopharmaceutical company, founded in 2012 by …See details»
Prexton Therapeutics SA Overview | SignalHire Company Profile
Prexton Therapeutics SA is a private company that has been in the industry for 12 years. The company currently specializes in the Pharmaceuticals, Biotechnology areas. The position of …See details»
Prexton Therapeutics (Netherlands) - Drug pipelines, Patents, …
Explore Prexton Therapeutics (Netherlands) with its drug pipeline, therapeutic area, technology platform, .See details»
Prexton Therapeutics SA: Contact Details and Business Profile
Prexton Therapeutics SA is a Pharmaceutical Manufacturing, Biotechnology, and Health Care company located in Plan-les-Ouates, Geneva with $9.00 Million in revenue and 5 employees. …See details»
Prexton Therapeutics SA - Drug pipelines, Patents, Clinical trials ...
Explore Prexton Therapeutics SA with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, Drug:Foliglurax.See details»
Prexton Therapeutics AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Prexton Therapeutics AG of Glattbrugg, ZURICH. Get the latest business insights from Dun & Bradstreet.See details»
Prexton Therapeutics (Switzerland) Funding: $41.1M
Nov 23, 2024 Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life of people who suffer from Parkinson's disease and other brain disorders. Prexton …See details»
Nextsource | Company Profile | Prexton Therapeutics
Explore the company profile of Prexton Therapeutics (prextontherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Prexton Therapeutics - Contacts, Employees, Board Members
Organization. Prexton Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Number of Board Member and Advisor Profiles 3. …See details»
M&A of the Year: Prexton Therapeutics - M Ventures
Jan 31, 2019 Having emerged from the Merck KGaA, Darmstadt, Germany Serono Entrepreneur Partnership Program (EPP) in 2015, Prexton Therapeutics raised a total $41m of funding …See details»
Prexton Therapeutics - Company Profile - Tracxn
Oct 21, 2024 Prexton Therapeutics ranks 59th among 424 active competitors. 149 of its competitors are funded while 73 have exited. Overall, Prexton Therapeutics and its …See details»
Prexton Acquired by Lundbeck for up to €905m.
Mar 16, 2018 H. Lundbeck A/S (Lundbeck) and Seroba’s Investee Company, Prexton Therapeutics BV (Prexton), today announced the signing of a definitive agreement in which …See details»
Prexton Therapeutics - Sunstone
Prexton Therapeutics Prexton’s lead compound Foliglurax is a novel mGluR4 compound currently in clinical development for symptomatic treatment of OFF-time reduction in Parkinson’s …See details»
M&A of the Year: Prexton Therapeutics - Global Venturing
Jan 31, 2019 Having emerged from the Merck Serono Entrepreneur Partnership Program (EPP) in 2015, Prexton Therapeutics raised a total $41m of funding before it was acquired by …See details»
Prexton Therapeutics SA - startup.ch
Prexton Therapeutics SA : Recently founded in Geneva, Switzerland, Prexton Therapeutics is developing novel mGluR4 PAM series, which were originally developed by Merck Serono, an …See details»
Prexton Therapeutics CEO and Key Executive Team | Craft.co
Prexton Therapeutics's key executives include Delphine Charvin and 1 others. Delphine Charvin. CSO. Duc Tran. COO. Source: prextontherapeutics.com. Report incorrect company …See details»
Pharma Company Buys Up MJFF-funded Biotech and Motor …
Danish pharmaceutical company Lundbeck last week bought Swiss biotech Prexton Therapeutics and, with it, its motor symptom therapy, foliglurax. The Michael J. Fox Foundation funded …See details»